
Getprise AI
Getprise AI provides Iris, a commercial reasoning operating system for specialty pharmaceutical launch teams. Iris continuously monitors formulary shifts, payer policy updates, and competitive moves, then interprets what those changes mean and drafts access strategies and coverage assessments. Built on purpose-built small language models, Iris delivers traceable, actionable outputs directly into existing workflows so cross-functional teams can coordinate faster during the critical post-approval launch window.
- Artificial Intelligence
- AI Agents
- Data & Analytics
- Software Only
- Enterprise Software
- Healthcare Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Specialty pharmaceutical launch teams face a 6–12 month post-approval coverage gap where launch trajectory is set, yet they must interpret complex market changes across fragmented functions. With 55% of HCPs having restricted or no rep access and $263 billion in U.S. specialty medicine spending, teams struggle to move in sync and act within narrow windows where intervention still matters.
Solution
Iris is a commercial reasoning operating system purpose-built for pharma that works like a cross-functional commercial expert trained on launch patterns, in-market performance, and the actions required to improve uptake. It continuously monitors formulary shifts, payer policy updates, adjudication patterns, and competitive moves, surfacing what matters inside the window where teams can still act. Iris interprets payer changes, drafts access strategies, and identifies where coverage or pull-through is breaking, then collaborates with users who can question, adjust assumptions, and finalize work together. The platform delivers outputs directly into the flow of work, enabling faster responses, coordinated action across teams, and forecasts that teams can defend. Rather than simply retrieving information, Iris reasons across the commercial landscape to help experts question, reason, and decide differently under complexity.
Target Audience
Primary customers are specialty pharmaceutical commercial launch teams, including market access, payer strategy, sales, and marketing functions that need coordinated interpretation of market signals during the post-approval launch window.
Features
- Continuous detection of formulary shifts, payer policy updates, adjudication patterns, and competitive moves with real-time monitoring
- Reasoning engine built on purpose-built small language models that interprets market changes and drafts access strategies, coverage assessments, and pull-through gap analyses
- Traceable recommendations where every answer and signal is explained with context on what it means, why it matters, and how urgent it is
- Collaborative workflow where users question outputs, adjust assumptions, and finalize deliverables alongside the AI
- Role-specific deployment for each commercial team with objectives and guardrails, replacing manual stitching of fragmented market data
- Action-oriented outputs delivered into existing workflows, supporting faster response times and defensible forecasting